Meeting
2014 ASCO Annual Meeting
The CXCL12/CXCR4 pathway, bone marrow-derived myeloid cells, and survival in locally advanced cervical cancer.
Authors
Naz Chaudary
Ontario Cancer Institute/The Campbell Family Institute for Cancer Research,Princess Margaret Cancer Centre Toronto, Ontario, Canada, Toronto, ON, Canada
Naz Chaudary , Melania Pintilie , Salomeh Jelveh , Patricia Lindsay , Rachel Glicksman , Blaise Clarke , Richard P. Hill , Michael Milosevic
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Radiation Biology
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 11122)
DOI
10.1200/jco.2014.32.15_suppl.11122
Abstract #
11122
Poster Bd #
404
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Association of next generation sequencing characteristics of MIBC specimens with clinical outcomes: The USC experience.
First Author: Arnab Basu
Poster
2016 ASCO Annual Meeting
Cisplatin (C)-paclitaxel (P) chemotherapy (CT) regimen with concurrent radiotherapy (RT) in local advanced (LACC) or recurrent (LRCC) cervical cancer: 14 year-results of a phase II study.
First Author: Milena Bruzzone
Poster
2024 ASCO Breakthrough
Analysis of prognostic factors in uterine cervical malignancy treated with concurrent chemoradiation therapy: A retrospective study in two centers in Korea.
First Author: Seung-Mi Lee
Poster
2024 ASCO Genitourinary Cancers Symposium
Efficacy and safety of the combination of cisplatin plus nab-paclitaxel and nivolumab with radiotherapy after maximal tumor resection in non-metastatic muscle invasive bladder cancer (CNN-BC trial).
First Author: Chiara Ciccarese